GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies

Research has led to the development of tailored treatment options for different cancers in different patients. Despite some treatments being able to provide remarkable responses, nearly all current treatments encounter the same issue: resistance. Here, we discuss our experiences with how breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Khoa, McConnell, Emily, Edwards, Orielle, Collins-Burow, Bridgette M., Burow, Matthew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511804/
https://www.ncbi.nlm.nih.gov/pubmed/36176759
http://dx.doi.org/10.20517/cdr.2022.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511804/
https://www.ncbi.nlm.nih.gov/pubmed/36176759
http://dx.doi.org/10.20517/cdr.2022.30

Ejemplares similares